Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated administration of DSP-5423P in patients with schizophrenia
jRCT2080222373Phase 1
- Sponsor
- Sumitomo Pharma
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of Blonanserin transdermal patch in schizophrenia, sponsored by Sumitomo Pharma.
02
Drugs
Blonanserin transdermal patch
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080222373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222373.